Alois B. Lang
Corporate Officer/Principal presso University of Bern
Profilo
Alois B.
Lang was the founder of Kenta Biotech AG, where he held the title of Chief Scientific Officer in 2006.
Currently, he is a Professor-Immunology at the University of Bern.
Previously, he worked as the Chief Development Officer at GeNeuro SA (Switzerland).
Dr. Lang obtained his doctorate degree from the Swiss Federal Institute of Technology.
Posizioni attive di Alois B. Lang
Società | Posizione | Inizio |
---|---|---|
University of Bern | Corporate Officer/Principal | - |
Precedenti posizioni note di Alois B. Lang
Società | Posizione | Fine |
---|---|---|
GENEURO SA | Corporate Officer/Principal | 31/12/2018 |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Founder | - |
Formazione di Alois B. Lang
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GENEURO SA | Health Technology |
Aziende private | 1 |
---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Alois B. Lang